Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Assembly of the cochlear gap junction macromolecular complex requires connexin 26
Kazusaku Kamiya, … , Osamu Minowa, Katsuhisa Ikeda
Kazusaku Kamiya, … , Osamu Minowa, Katsuhisa Ikeda
Published March 3, 2014
Citation Information: J Clin Invest. 2014;124(4):1598-1607. https://doi.org/10.1172/JCI67621.
View: Text | PDF
Research Article Cell biology

Assembly of the cochlear gap junction macromolecular complex requires connexin 26

  • Text
  • PDF
Abstract

Hereditary deafness affects approximately 1 in 2,000 children. Mutations in the gene encoding the cochlear gap junction protein connexin 26 (CX26) cause prelingual, nonsyndromic deafness and are responsible for as many as 50% of hereditary deafness cases in certain populations. Connexin-associated deafness is thought to be the result of defective development of auditory sensory epithelium due to connexion dysfunction. Surprisingly, CX26 deficiency is not compensated for by the closely related connexin CX30, which is abundantly expressed in the same cochlear cells. Here, using two mouse models of CX26-associated deafness, we demonstrate that disruption of the CX26-dependent gap junction plaque (GJP) is the earliest observable change during embryonic development of mice with connexin-associated deafness. Loss of CX26 resulted in a drastic reduction in the GJP area and protein level and was associated with excessive endocytosis with increased expression of caveolin 1 and caveolin 2. Furthermore, expression of deafness-associated CX26 and CX30 in cell culture resulted in visible disruption of GJPs and loss of function. Our results demonstrate that deafness-associated mutations in CX26 induce the macromolecular degradation of large gap junction complexes accompanied by an increase in caveolar structures.

Authors

Kazusaku Kamiya, Sabrina W. Yum, Nagomi Kurebayashi, Miho Muraki, Kana Ogawa, Keiko Karasawa, Asuka Miwa, Xueshui Guo, Satoru Gotoh, Yoshinobu Sugitani, Hitomi Yamanaka, Shioko Ito-Kawashima, Takashi Iizuka, Takashi Sakurai, Tetsuo Noda, Osamu Minowa, Katsuhisa Ikeda

×

Figure 1

Drastic disruption of cochlear GJPs in two models of CX26-associated deafness.

Options: View larger image (or click on image) Download as PowerPoint
Drastic disruption of cochlear GJPs in two models of CX26-associated dea...
(A) Schematic illustration of cochlear ISCs. (B and C) CX26 distribution (in red) in ISCs (boxed region in A) in P12 cochlear cryosections from CX26R75W+ mice show fragmented GJPs (C, small arrows) in contrast to GJPs in control mice (B). (D and E) Double staining of CX26 and CX30 in whole-mount cochlear tissue at 3 weeks showing that these GJPs are composed of both connexins in control (D) and CX26R75W+ (E) mice. (F–H) GJP formation in 8-week-old adult cochleae from a CX26R75W+ mouse (G), a non-Tg littermate control (F), and a Cx26f/f P0-Cre mouse (H). The partial EGFP signals in G indicate that it is a transgenic animal. (I–K) Image of each boxed region in F–H, respectively. Inset in K shows the GJPs in a Cx26f/f littermate control mouse. (L–N) Three-dimensional images reconstructed from the images in I–K, respectively. (O) Lengths of the largest GJPs (brackets in I–K) along a single cell border (mean ± SE, n = 25 for all four groups). ***P = 4.7 × 10–14 and 1.2 × 10–16 for CX26R75W+ and Cx26f/f P0-Cre cochleae, respectively, relative to controls (Student’s t test). (P–R) At E17.5, CXx26R75W+ ISCs showed a number of S-GJPs (Q, arrows), including some L-GJPs (Q, arrowheads), as observed in the non-Tg control ISCs (P). Cx26f/f P0-Cre ISCs (R) showed totally disrupted GJPs, although the control ISCs (Cx26f/f, inset in R) showed L-GJPs. Nuclei were counterstained with DAPI (blue). Scale bars: 10 μm.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts